神经血管器材市场机会、成长驱动因素、产业趋势分析及预测（2026-2035年）

全球神经血管器械市场预计到 2025 年将达到 50 亿美元，并预计以 5.2% 的复合年增长率成长，到 2035 年达到 85 亿美元。

随着全球医疗系统面临日益严峻的神经血管疾病挑战，神经血管器材市场正稳定成长。在对有效治疗方法需求不断增长的推动下，医院和专科医疗中心正越来越多地采用旨在治疗复杂脑血管疾病的先进医疗技术。推动这一增长的另一个关键因素是全球老年人口的增加，他们更容易患上影响大脑和中枢神经系统的血管疾病。器械工程、材料科学和诊断影像技术的不断整合也有助于提高治疗效率和临床疗效。此外，医疗机构越来越倾向于微创手术，这使得医生能够更精准地治疗复杂的血管疾病，同时缩短患者復原时间并降低手术风险。许多地区的政府正在投资医疗现代化和改善先进医疗技术的可近性，这进一步促进了神经血管器械市场的发展。因此，医疗机构正越来越多地采用创新的介入神经放射学系统，以提高诊断准确性、治疗精准度并支持患者的长期管理。

神经血管器械是指专门用于诊断、治疗和管理影响大脑和中枢神经系统血管疾病的医疗器械和植入。这些器械通常用于微创手术，旨在恢復正常血液循环、预防血管破裂并降低严重神经系统併发症的风险。器材设计、材料和功能的持续创新极大地改变了介入神经放射学手术。现代神经血管技术使医生能够进行高度精准的治疗，提高手术成功率并最大限度地减少併发症。随着器械性能的不断提升，医疗专业人员能够为复杂的脑血管疾病提供更快、更安全、更有效的治疗。这些技术进步正推动神经血管治疗从传统方法转向高度精确的系统，这些系统旨在支持微创治疗并改善患者的復健效果。

预计到2025年，栓塞线圈市场规模将达到8.474亿美元，市占率为16.9%。栓塞线圈是一种用于介入神经放射学手术的专用医疗设备，用于控製或阻断目标血管内的异常血流。这些器械透过促进受影响血管内可控血栓的形成来发挥作用，从而限制血管异常区域的血流。线圈设计、材料成分和传输技术的不断进步提高了这些器械的安全性和性能。更高的植入精度和器械柔软性也增强了医生对这些系统的信心，进一步加速了其在医疗机构中的应用，并促进了神经血管器械市场的整体扩张。

预计到2025年，脑血管造影术市场规模将达到8.783亿美元。脑血管造影术是一种基于导管的成像技术，用于评估大脑及其周围的血管。该技术能够极为清晰地显示血管结构，使医疗专业人员能够识别影响脑循环的异常情况。其产生精确动态影像的能力使其成为脑血管疾病诊疗中不可或缺的诊断工具。持续投入研发以改善血管造影术技术，正推动先进影像系统的问世。这些创新增强了诊断能力，并促进了用于成像程序的神经血管设备的普及，从而推动了市场扩张。

预计到2025年，北美神经血管器械市占率将达到34.7%。该地区预计将继续保持强劲成长，这得益于其先进的医疗基础设施和医疗设备研发领域的快速技术进步。该地区的医疗机构正日益将创新的神经血管技术应用于临床实践，以提高治疗效率并改善患者预后。美国凭藉着强大的研发能力和广泛的专业医疗设施，在先进介入神经放射学器材的研发和应用方面发挥核心作用。对医疗创新持续投入，以及对先进神经血管疗法日益增长的需求，巩固了该地区在全球神经血管器材市场的主导地位。

全球神经血管器材市场涵盖众多领导企业，例如旭硝子（Asahi Intecc）、Acandis、Blockade Medical、Balt Extrusion、Integer Holdings Corporation、强生（Johnson & Johnson）、Kaneka Medix Corp、美敦力（Medtronic）、Merit Medical System、微创医疗（MicroPort Scientic Corporation、美敦力（Medtronic）、Merit Medical System、微创医疗（MicroPort Scientific Corporation）、Penbra、Pencoco） Corporation）。主要企业正积极实施各种策略，以巩固市场地位并拓展全球业务。主要企业大力投资研发，致力于推出能提高治疗精准度、手术安全性和临床疗效的先进器械。产品创新始终是企业关注的焦点，尤其註重开发微创技术，并透过材料和设计改进来提升器材性能。与医疗和研究机构建立策略合作伙伴关係也有助于企业加速技术进步并扩大临床应用。许多製造商正透过建构销售网络和在新兴医疗市场建立合作伙伴关係来拓展地域版图。此外，各企业都在积极争取新产品的监管核准，并不断扩展产品组合，以满足多样化的神经血管治疗需求，从而在神经血管器械市场保持长期竞争力。

目录

第一章：调查方法和范围

第二章执行摘要

第三章业界考察

• 产业生态系分析
• 影响产业的因素
  • 成长驱动因素
    • 神经系统疾病盛行率增加
    • 对微创手术的需求日益增长
    • 神经血管装置的技术进步
    • 老年人口增加
  • 产业潜在风险与挑战
    • 医疗设备高成本
    • 严格的法规环境
  • 市场机会
    • 新兴国家医疗保健产业的扩张
• 成长潜力分析
• 监理情势
  • 北美洲
  • 欧洲
  • 亚太地区
• 技术进步
  • 当前技术趋势
  • 新兴技术
• 未来市场趋势
• 人工智慧和生成式人工智慧对市场的影响
• 波特五力分析
• PESTEL 分析

第四章 竞争情势

• 介绍
• 企业市占率分析
• 企业矩阵分析
• 主要市场公司的竞争分析
• 竞争定位矩阵
• 主要进展
  • 併购
  • 伙伴关係与合作
  • 新产品发布
  • 业务拓展计划

第五章 市场估价与预测：依产品划分，2022-2035年

• 栓塞线圈
• 颈动脉支架
• 颅内支架
• 导管
• 栓塞预防装置
• 分流器
• 神经血栓除去装置
• 膀胱内装置
• 气球系统
• 血栓摘取支架
• 导管导引线
• 其他产品

第六章 市场估计与预测：依治疗方法划分，2022-2035年

• 神经血栓切除术
• 脑血管造影术
• 颈动脉切除术
• 支架置入术
• 显微外科夹闭术
• 卷绕
• 流向
• 其他措施

第七章 市场估计与预测：依治疗应用划分，2022-2035年

• 脑动脉瘤
• 收缩
• 缺血性中风
• 其他治疗用途

第八章 市场估算与预测：依最终用途划分，2022-2035年

• 医院
• 门诊手术中心
• 诊所
• 其他最终用户

第九章 市场估计与预测：依地区划分，2022-2035年

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿拉伯聯合大公国

第十章：公司简介

• Asahi Intecc
• Acandis
• Blockade Medical
• Balt Extrusion
• Integer Holdings Corporation
• Johnson &Johnson
• Kaneka Medix Corp
• Medtronic
• Merit Medical System
• MicroPort Scientific Corporation
• Penumbra
• Phenox
• Stryker
• Sensome
• Terumo Corporation

The Global Neurovascular Devices Market was valued at USD 5 billion in 2025 and is estimated to grow at a CAGR of 5.2% to reach USD 8.5 billion by 2035.

The neurovascular devices market is witnessing steady expansion as healthcare systems worldwide face a growing burden of neurological vascular disorders. Rising demand for effective treatment solutions is encouraging hospitals and specialized care centers to adopt advanced medical technologies designed to manage complex cerebrovascular conditions. Another major factor supporting growth is the increasing global elderly population, which is more vulnerable to vascular disorders affecting the brain and central nervous system. Continuous progress in device engineering, material science, and imaging integration is also contributing to improvements in treatment efficiency and clinical outcomes. In addition, healthcare providers are increasingly favoring minimally invasive procedures that allow physicians to treat complex vascular conditions with greater precision while reducing patient recovery times and surgical risks. Governments in multiple regions are investing in healthcare modernization and improving access to advanced medical technologies, further supporting the development of the neurovascular devices market. As a result, healthcare institutions are increasingly integrating innovative neuro-interventional systems that enhance diagnostic accuracy, improve treatment precision, and support better long-term patient management.

Neurovascular devices refer to specialized medical instruments and implants designed to diagnose, treat, and manage disorders affecting the blood vessels of the brain and central nervous system. These devices are commonly used in minimally invasive procedures aimed at restoring healthy blood circulation, preventing vascular rupture, and lowering the risk of serious neurological complications. Continuous innovation in device design, materials, and functionality has significantly transformed neuro-interventional procedures. Modern neurovascular technologies enable physicians to perform highly precise treatments that improve procedural success rates while minimizing complications. As device capabilities continue to advance, healthcare professionals can deliver faster, safer, and more effective interventions for complex cerebrovascular conditions. The evolution of these technologies has shifted neurovascular treatment from conventional approaches toward highly sophisticated systems designed to support minimally invasive therapeutic procedures and improve patient recovery outcomes.

The embolic coils segment generated USD 847.4 million in 2025 and accounted for 16.9% share. Embolic coils are specialized medical devices utilized in neuro-interventional procedures to control or block abnormal blood flow within targeted vessels. These devices work by promoting controlled clot formation inside the affected vessel, which helps restrict circulation in areas where vascular abnormalities are present. Continuous advancements in coil design, material composition, and delivery technologies have enhanced the safety and performance of these devices. Improvements in deployment accuracy and device flexibility have also strengthened physician confidence in these systems, further encouraging their adoption across healthcare facilities and contributing to the overall expansion of the neurovascular devices market.

The cerebral angiography segment generated USD 878.3 million in 2025. Cerebral angiography is a catheter-based diagnostic imaging procedure used to evaluate blood vessels within the brain and surrounding regions. The technique provides a highly detailed visualization of vascular structures, allowing healthcare professionals to identify abnormalities affecting cerebral circulation. Its ability to produce precise and dynamic imaging makes it an essential diagnostic tool in neurovascular care. Continuous investment in research and product development aimed at improving angiography technologies is leading to the introduction of advanced imaging systems. These innovations are enhancing diagnostic capabilities and supporting the broader adoption of neurovascular devices used in imaging procedures, which is contributing to market expansion.

North America Neurovascular Devices Market accounted for 34.7% share in 2025. The region continues to experience strong growth supported by advanced healthcare infrastructure and rapid technological progress in medical device development. Healthcare providers in the region are increasingly integrating innovative neurovascular technologies into clinical practice to improve treatment efficiency and patient outcomes. The United States plays a central role in both the development and adoption of advanced neuro-interventional devices, supported by strong research capabilities and widespread access to specialized healthcare facilities. Ongoing investments in healthcare innovation, combined with increasing demand for advanced neurovascular treatments, continue to support the region's leading position in the global neurovascular devices market.

Several key companies operate in the Global Neurovascular Devices Market, including Asahi Intecc, Acandis, Blockade Medical, Balt Extrusion, Integer Holdings Corporation, Johnson & Johnson, Kaneka Medix Corp, Medtronic, Merit Medical System, MicroPort Scientific Corporation, Penumbra, Phenox, Stryker, Sensome, and Terumo Corporation. Companies participating in the Global Neurovascular Devices Market are implementing a range of strategies to strengthen their market position and expand global reach. Major players are investing significantly in research and development to introduce advanced devices that improve treatment precision, procedural safety, and clinical efficiency. Product innovation remains a central focus, particularly in developing minimally invasive technologies and enhancing device performance through improved materials and engineering. Strategic partnerships with healthcare institutions and research organizations are also helping companies accelerate technological advancements and expand clinical adoption. Many manufacturers are pursuing geographic expansion by establishing distribution networks and collaborations in emerging healthcare markets. In addition, companies are actively working to secure regulatory approvals for new products while broadening their device portfolios to address diverse neurovascular treatment needs and maintain long-term competitiveness in the neurovascular devices market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Process trends
  • 2.2.4 Therapeutic application trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of neurological diseases
    • 3.2.1.2 Rising demand for minimally invasive surgical procedures
    • 3.2.1.3 Technological advancement in neurovascular devices
    • 3.2.1.4 Growing geriatric population base
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Stringent regulatory scenario
  • 3.2.3 Market opportunities
    • 3.2.3.1 Growing healthcare expansion in emerging economies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Impact of AI and generative AI on the market
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Embolic coils
• 5.3 Carotid stents
• 5.4 Intracranial stents
• 5.5 Catheters
• 5.6 Embolic protection devices
• 5.7 Flow diverters
• 5.8 Neurothrombectomy devices
• 5.9 Intrasaccular devices
• 5.10 Balloon systems
• 5.11 Stent retrievers
• 5.12 Guidewires
• 5.13 Other products

Chapter 6 Market Estimates and Forecast, By Process, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Neurothrombectomy
• 6.3 Cerebral angiography
• 6.4 Carotid endarterectomy
• 6.5 Stenting
• 6.6 Microsurgical clipping
• 6.7 Coiling
• 6.8 Flow diversion
• 6.9 Other processes

Chapter 7 Market Estimates and Forecast, By Therapeutic Applications, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Brain aneurysm
• 7.3 Stenosis
• 7.4 Ischemic strokes
• 7.5 Other therapeutic applications

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Clinics
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Asahi Intecc
• 10.2 Acandis
• 10.3 Blockade Medical
• 10.4 Balt Extrusion
• 10.5 Integer Holdings Corporation
• 10.6 Johnson & Johnson
• 10.7 Kaneka Medix Corp
• 10.8 Medtronic
• 10.9 Merit Medical System
• 10.10 MicroPort Scientific Corporation
• 10.11 Penumbra
• 10.12 Phenox
• 10.13 Stryker
• 10.14 Sensome
• 10.15 Terumo Corporation